Frequently, there can be a separation between the strength of recommendation and quality of evidence. ErratumAnnals of Allergy, Asthma & ImmunologyVol. 116Issue 3PreviewIn the article entitled “Anaphylaxis—a practice parameter update 2015” (Ann Allergy Asthma Immunol 2015;115:341-384), the dose of glucagon in children was incorrect. The correct dosage is as follows: Full-Text PDF Authors' responseAnnals of Allergy, Asthma & ImmunologyVol. 116Issue 3PreviewThank you so much for your interest in our parameters1 and your very helpful letter.2 We greatly appreciate your comments. As far as the dose of glucagon is concerned, we have added an erratum to the Annals.3 Full-Text PDF Refractory anaphylaxis: further considerations for emergency care providersAnnals of Allergy, Asthma & ImmunologyVol. 116Issue 3PreviewWe read with great interest the 2015 update of the anaphylaxis practice parameter by Lieberman and colleagues.1 Several aspects of this update are particularly relevant to clinicians in emergency medicine, especially the sections on “Office Management of Anaphylaxis” and “Controversies and Unsettled Issues Related to Patients at Risk for or Being Treated for Anaphylaxis.” However, we believe that there are also several issues included in the update that require clarification based on the current literature. Full-Text PDF Recently published anaphylaxis practice parameterAnnals of Allergy, Asthma & ImmunologyVol. 116Issue 3PreviewDuring our journal club today, we read with appreciation and enthusiasm the anaphylaxis practice parameter published in the November issue of the Annals.1 We noted 3 typographical errors. Full-Text PDF Authors' responseAnnals of Allergy, Asthma & ImmunologyVol. 116Issue 3PreviewThank you very much for pointing out the errors in the parameter.1,2 We greatly appreciate your help. Full-Text PDF